| Literature DB >> 25693200 |
Sophie Bertrand1, Guillaume De Lamine de Bex1, Christa Wildemauwe1, Octavie Lunguya2, Marie France Phoba2, Benedikt Ley3, Jan Jacobs4, Raymond Vanhoof1, Wesley Mattheus1.
Abstract
Surveillance of Salmonella enterica subsp. enterica serovar Enteritidis is generally considered to benefit from molecular techniques like multiple-locus variable-number of tandem repeats analysis (MLVA), which allow early detection and confinement of outbreaks. Here, a surveillance study, including phage typing, antimicrobial susceptibility testing and MLVA on 1,535 S. Enteritidis isolates collected between 2007 and 2012, was used to evaluate the added value of MLVA for public health surveillance in Belgium. Phage types PT4, PT8, PT21, PT1, PT6, PT14b, PT28 and PT13 dominate the Belgian S. Enteritidis population. The isolates of S. Enteritidis were most frequently susceptible to all antibiotics tested. 172 different MLVA profiles were detected, of which 9 frequent profiles included 67.2% of the S. Enteritidis population. During a serial passage experiment on selected isolates to investigate the in vitro stability of the 5 MLVA loci, no variations over time were observed indicating that the MLVA profiles were stable. The MLVA profile of isolates originating from different outbreaks in the Democratic Republic of the Congo (DRC) between 2010 and 2011 were distinct from any of the MLVA profiles found in Belgian isolates throughout the six year observational period and demonstrates that MLVA improves public health surveillance of S. Enteritidis. However, MLVA should be complemented with other subtyping methods when investigating outbreaks is caused by the most common MLVA profile.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25693200 PMCID: PMC4334661 DOI: 10.1371/journal.pone.0117950
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Phage type distribution among the S. Enteritidis population over the 6-year period (n- = 1,498; other: all phage types with less than 3% occurrence in the same combined population.
Overview of antimicrobial resistance and MLVA characteristics in relation to the phage type (n = 1,498).
| Phage type | Nb. isolates (% of total) | Nb. susceptible isolates (%) | Nb. MDR isolates (%) | Most common resistance patterns (% of isolates with resistance pattern) | Nb. MLVA types | Most common MLVA profiles (SENTR7-SENTR5-SENTR6-SENTR4-SE-3) (% of isolates with MLVA profile) |
|---|---|---|---|---|---|---|
| PT4 | 284 (19.0) | 253 (89,1) | 4 (1.4) | Amp (1.1), Nal (8.5) | 51 | 3–10–5–4–1 (38.2),3–11–5–4–1 (10.9) |
| PT8 | 279 (18.6) | 274 (98.2) | 1 (0.4) | Nal (0.4), Ctx (0.4), AmpCtxTetTmpSpeNalStrSulSxt (0.4) | 40 | 2–10–7–3–2 (35.5), 2–11–7–3–2 (14.3) |
| PT21 | 245 (16.3) | 235 (95.9) | 3 (1.2) | Nal (2.0) | 24 | 3–10–5–4–1 (27.7), 3–11–5–4–1 (27.3) |
| PT1 | 176 (11.7) | 137 (77.8) | 1 (0.6) | Nal (20.5), AmpAmxNal (1.1) | 28 | 3–10–5–4–1 (68.6) |
| PT6 | 127 (8.5) | 120 (94.5) | 1 (0.8) | Amp (10.2), Nal (3.9) | 24 | 3–10–5–4–1 (36.2), 3–9–5–4–1 (12.6), 3–10–5–3–1 (11.0) |
| PT14b | 69 (4.6) | 53 (76.8) | 1 (1.5) | Nal (21.7) | 15 | 2–13–7–3–2 (34.8), 3–10–5–4–1 (17.4) |
| PT28 | 61 (4.1) | 61 (100) | 0 (0) | - | 21 | 2–10–7–3–2 (44.3) |
| PT13 | 51 (3.4) | 27 (52.9) | 0 (0) | Nal (9.8) | 27 | 2–10–7–3–2 (15.7), 3–10–5–4–1 (7.8), 2–10–8–5–2 (7.8) |
| Other | 206 (13.7) | 162 (78.6) | 8 (3.9) | Nal (8.7), AmpTet (1.9) | 67 | 3–10–5–4–1 (17.9), 3–11–5–4–1 (9.2), 3–9–5–4–1 (7.7) |
MDR: multidrug resistant; MLVA: multiple-locus variable-number of tandem repeats analysis; Other: phage types with less than 3% occurrence in the isolate panel; Amp: ampicillin; Amx: amoxicillin plus clavulanic acid; Chl: chloramphenicol; Nal: nalidixic acid; Str: streptomycin; Sul: sulphonamides; Sxt: trimethoprim plus sulfamethoxazole, Tet: tetracycline; Tmp: trimethoprim
Fig 2a: Annual distribution of Belgian S. Enteritidis isolates over the 6-year period according to the nine most frequent MLVA profiles (representing 1,006 of the 1,498; 67.2%).
b: Prevalence of S. Enteritidis isolates in this study with the most frequent MLVA profile and with indication of the major phage type (representing 902 of the 1,498; 60.2%).
Fig 3Minimal spanning tree calculated of MLVA profiles of S. Enteritidis isolates over the 6-year period.
Each node represents a different MLVA profile with frequency-dependent size. Node colour represents phage type: Branch thickness indicates how many loci are different in the MLVA profiles of the connected nodes. Thick solid lines connect nodes that differ by one MLVA locus, thin solid lines connect nodes that differ by two MLVA loci and dashed lines connect nodes that differ by three MLVA loci.
Overview of isolates and outcome of the stability experiment for the Belgian isolates(n = 22).
| ID Number | Phage Type | Initial MLVA profile | Final MLVA profile | Frequence of the Phage type and MLVA profile (%/%) |
|---|---|---|---|---|
| SE1: 07–1456 | PT8 | 2–13–7–3–2 | 2–13–7–3–2 | 18.6/3.1 |
| SE2: 07–5973 | PT28 | 2–12–7–3–2 | 2–12–7–3–2 | 4.1/0.01 |
| SE3: 09–2821 | PT8 | 2–13–7–3–2 | 2–13–7–3–2 | 18.6/3.1 |
| SE4: 11–2950 | PT28 | 2–10–7–3–2 | 2–10–7–3–2 | 4.1/9.5 |
| SE5: 12–0215 | PT14b | 2–13–7–3–2 | 2–13–7–3–2 | 4.6/3.1 |
| SE6: 12–0266 | PT4 | 3–9–5–4–1 | 3–9–5–4–1 | 19/6.7 |
| SE7: 12–0429 | PT21 | 3–11–5–4–1 | 3–11–5–4–1 | 16.3/9.2 |
| SE8: 12–1442 | PT21 | 3–11–5–4–1 | 3–11–5–4–1 | 16.3/9.2 |
| SE9: 12–2353 | P13 | 2–12–7–3–2 | 2–12–7–3–2 | 3.4/0.01 |
| SE10: 12–2488 | PT21 | 3–9–5–4–1 | 3–9–5–4–1 | 16.3/6.7 |
| SE11: 12–2592 | PT14b | 3–10–5–4–1 | 3–10–5–4–1 | 4.6/26.8 |
| SE12: 12–2630 | PT21 | 3–10–5–4–1 | 3–10–5–4–1 | 16.3/26.8 |
| SE13: 12–3578 | PT1 | 3–10–5–4–1 | 3–10–5–4–1 | 11.7/26.8 |
| SE14: 12–3599 | PT4 | 3–11–5–4–1 | 3–11–5–4–1 | 19/9.2 |
| SE15: 12–3693 | PT4 | 3–10–5–4–1 | 3–10–5–4–1 | 19/26.8 |
| SE16: 12–3723 | PT8 | 2–10–7–3–2 | 2–10–7–3–2 | 18.6/9.5 |
| SE17: 12–4071 | PT8 | 2–11–7–2–2 | 2–11–7–2–2 | 18.6/3.4 |
| SE18: 12–4164 | PT8 | 2–11–7–2–2 | 2–11–7–2–2 | 18.6/3.4 |
| SE19: 12–4561 | PT8 | 2–11–7–3–2 | 2–11–7–3–2 | 18.6/3.4 |
| SE20: 12–4593 | PT4 | 3–10–5–3–1 | 3–10–5–3–1 | 19/2.4 |
| SE21: 12–4666 | PT6 | 3–10–5–3–1 | 3–10–5–3–1 | 8.5/2.4 |
| SE22: 12–4775 | PT4 | 3–11–5–3–1 | 3–11–5–3–1 | 19/3.6 |
Overview of isolates and outcome of the stability experiment for the outbreak isolates from Congo (n = 5).
| ID Number | Initial MLVA profile | Final MLVA profile | Frequence of the MLVA profile (n/37) |
|---|---|---|---|
| SE23: 3303–3 Congo | 2–16–3–3-NA | 2–16–3–3-NA | 2/37 |
| SE24: 3339–3 Congo | 2–15–3–3-NA | 2–15–3–3-NA | 14/37 |
| SE25: 3493–3 Congo | 2–15–3–3-NA | 2–15–3–3-NA | 14/37 |
| SE26: 3522 Congo | 2–14–3–3-NA | 2–14–3–3-NA | 4/37 |
| SE27: 3680 Congo | 2–14–3–3-NA | 2–14–3–3-NA | 4/37 |